Literature DB >> 8483247

Current management of invasive and metastatic transitional cell carcinoma of the bladder.

J B Thrasher1, E D Crawford.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8483247     DOI： 10.1016/s0022-5347(17)36270-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  12 in total

1.  E-cadherin expression in transitional cell carcinomas.

Authors:  Eszter Székely; Virág Török; Tamás Székely; Péter Riesz; Imre Romics
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

2.  Spatially controlled photothermal heating of bladder tissue through single-walled carbon nanohorns delivered with a fiberoptic microneedle device.

Authors:  R Lyle Hood; William F Carswell; Amanda Rodgers; Mehmet A Kosoglu; Marissa Nichole Rylander; David Grant; John L Robertson; Christopher G Rylander
Journal:  Lasers Med Sci       Date:  2012-10-04       Impact factor: 3.161

3.  Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.

Authors:  Laurence Booth; Jane L Roberts; Nichola Cruickshanks; Adam Conley; David E Durrant; Anindita Das; Paul B Fisher; Rakesh C Kukreja; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Mol Pharmacol       Date:  2013-12-18       Impact factor: 4.436

Review 4.  ABC of Urology. Urological malignancy--II: Urothelial tumours.

Authors:  C Dawson; H Whitfield
Journal:  BMJ       Date:  1996-04-27

5.  Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.

Authors:  R Baffa; L G Gomella; A Vecchione; P Bassi; K Mimori; J Sedor; C M Calviello; M Gardiman; C Minimo; S E Strup; P A McCue; A J Kovatich; F Pagano; K Huebner; C M Croce
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.

Authors:  G I Murray; V E Taylor; J A McKay; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

Review 7.  From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists.

Authors:  G H Mickisch; F H Schroeder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

8.  The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.

Authors:  K Cam; A Yildirim; H Ozveri; L Turkeri; A Akdas
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma.

Authors:  Ismail Turker Koksal; Mutlu Ates; Ahmet Danisman; Cem Sezer; Akif Ciftcioglu; Gulten Karpuzoglu; Metin Sevuk
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

10.  M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.

Authors:  M Igawa; H Kadena; M Ueda; T Usui
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.